Cherwell has contacted the RISE and 2020 Vision campaigns for comment. 2020 Vision were also successful in nomination the candidates with the most first preference votes in the races for Standing Committee (Chengkai Xie), and Secretary’s Committee (Geneva Roy). Speaking to Cherwell about the results, Unlock the Union said: “We are, of course, disappointed with this morning’s results. But we are also so proud of every member of our team, they’ve all put in so much work – and we are really pleased for the members of our team who were successful. Dube, Barr, and Cohen will serve their terms as President, Treasurer, and Librarian in Hilary term of 2020, while Lee will assume the role of Secretary in Michaelmas term of 2019. “We wish both other campaigns the best and hope that the winning officers will push for the substantial change the Union needs.” The night was disappointing for the Unlock the Union slate, who took 1 of the 7 places on Standing Committee and 2 of the 11 places on Secretary’s Committee. By contrast, RISE claimed 2 places on Standing Committee, while 2020 Vision won 3, and RISE saw 5 of its candidates elected to Secretary’s Committee to 2020 Vision’s 4. “I hope to affirm their confidence in me next term by acting as a voice for change in the union, and by delivering on my pledge to hold a referendum on the question of abolishing slates.” The closely-fought three-way election was fought on a number of issues, with RISE pledging to spend less on committee and more on members, to negotiate a discounted Plush entry price for members, and to move the membership registration process online. 2020 Vision had pledged to offer £1 pints during happy hour at the Oxford Union bar, to organise movie screenings with actors and directors, and to invite more BME speakers. Unlock the Union’s offers included accrediting a living wage for all Union staff, filming YouTube debate tutorials, and tabling a referendum on banning slates. Sara Dube has been elected to serve as Oxford Union President in Hilary 2020 after a three way race that saw her claim 521 first preference votes over Charlie Coverman’s 355 and Amy Gregg’s 244. Candidates representing Dube’s “RISE” slate also succeeded in securing the offices of Treasurer-elect (Beatrice Barr) and Secretary-elect (Lee Chin Wee). One independent candidate, Joseph Grehan-Bradley, was successfully elected to Standing Committee. Speaking to Cherwell, Grehan-Bradley said: “I’m absolutely delighted to have been elected, and to have finished third. I’m so grateful to all the people who took time out from their busy schedules yesterday to drop me a vote. In the race for Librarian-elect – for which “RISE” did not nominate a candidate due to an incident in which the expected candidate, Ayman D’Souza, was instead nominated in the Treasurer-elect race – Coverman’s “2020 Vision” slate successfully elected Spencer Cohen in a close race with Mo Iman, a member of Gregg’s “Unlock the Union” slate.
Aug 16, 2007 (CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.HHS ordered enough vaccine in bulk form to provide 22.5 million 15-microgram (mcg) doses, the company announced on Aug 3. The order is in addition to the bulk equivalent of 5 million 15-mcg doses that HHS ordered in November 2006, officials said.The cost of the new vaccine order is $97 million, according to Marc Wolfson, a spokesman for the HHS Office of the Assistant Secretary for Preparedness and Response in Washington, DC.The new order includes 9 million doses produced in the 2006 “manufacturing campaign” and 13.5 million doses to be produced in the 2007 campaign, GSK reported. The vaccine is based on clade 2 strain of the H5N1 virus.GSK will make the bulk vaccine at its facility in Ste. Foy, Quebec, and store it in Marietta, Pa.When HHS announced the plan to buy H5N1 vaccine from GSK in November 2006, the agency said it was ordering 800,000 doses, not the 5 million doses cited in the company’s Aug 3 announcement. Wolfson of HHS and Ken Inchausti, a GSK spokesman in Philadelphia, explained that the two announcements involve the same amount of bulk vaccine, but the HHS statement was based on a dose of 90 mcg, whereas the company announcement assumed a dose of 15 mcg.”The confusion between the 5 million doses that GSK talks about and what we have is that we’re still ordering it at the bulk rate of 90 [mcg] per dose,” Wolfson told CIDRAP News. “They’re doing tests that could possibly take it down to 15 [mcg] per dose, and if you do the math, that’s where the difference comes.”Based on 90 mcg per dose, HHS currently has 2.3 million doses of GSK vaccine in its H5N1 vaccine stockpile, Wolfson reported.The vaccine contract provides that HHS may direct the company to formulate the bulk vaccine into doses in the future, GSK said. In addition, HHS has an option to buy the vaccine in combination with one of the company’s proprietary adjuvants, or immune-boosting chemicals, which could reduce the amount of vaccine antigen needed to induce a protective immune response, the company reported.Funds for the vaccine contract will come through the Biomedical Advanced Research and Development Authority (BARDA) in the HHS Office of the Assistant Secretary for Preparedness and Response, according to GSK.Clinical trial startingGSK also announced the start of the first North American clinical trial of its prepandemic H5N1 vaccine. The trial is described as a phase1/2 study that will compare the safety and immunogenicity of the H5N1 antigen alone and in combination with one of GSK’s adjuvant systems in 675 adult volunteers. Inchausti said the trial will be conducted at sites in Montana, California, Florida, Georgia, Alabama, Kansas, and Nevada and in Halifax and Quebec, Canada.The company said it plans to follow up later this year with a phase 3 trial that will involve about 4,400 volunteers. Results of the phase 1/2 trial are expected in early 2008.Last March, GSK reported that in a clinical trial, one of its adjuvanted H5N1 vaccines triggered a strong immune response with two 3.8-mcg doses, or about half of the 15-mcg dose typically used for each viral strain in seasonal flu vaccines. The company also said tests showed that the vaccine, based on a Vietnam strain of H5N1, generated cross-reactive immunity against an Indonesian strain.GSK, Baxter sign vaccine deals with UKIn other developments, both GSK and US-based Baxter International today announced agreements to sell vaccine to the United Kingdom in the event of a flu pandemic.Under the GSK agreement, the company will make preparations to provide a “tailored” vaccine as soon as possible after a pandemic is declared by the World Health Organization, according to a company news release. GSK said it also has agreements to sell pandemic vaccines to Switzerland, Denmark, and Iceland.Baxter, based in Deerfield, Ill., said its European subsidiary in the UK signed an agreement giving the UK an option to buy Baxter’s vaccine in the event of a pandemic. The company’s candidate pandemic vaccine is produced in vero cell culture rather than in eggs, the conventional medium for flu vaccine production. Baxter said it recently enrolled volunteers for a phase 3 clinical study of its cell-based H5N1 vaccine in Europe.See also: Mar 6 CIDRAP News story “Glaxo H5N1 vaccine may work against multiple strains”Nov 20, 2006, CIDRAP News story “HHS awards 3 contracts for more H5N1 vaccine”
LocalNews Landslide in Antrizile claims the life of Linus Sully by: – May 17, 2011 Photo credit: ckcbirds.co.ukPolice Public Relations Officer, Inspector Claude Weekes has confirmed the death of forty eight year old Linus Sully, a resident of the Antrizle community in the Kalinago Territory.It is reported that Mr. Sully, Gilbert Laville and another gentleman were walking under a cliff heading to fish at the time of this tragic and unfortunate incident.“Police are investigating the death of Linus Sully of Atkinson which took place on Monday 16th May, 2011 somewhere about 3:45pm. He along with others were heading to the bayside at Antrizle to do rock fishing when rocks and boulders came crashing on them, thats the deceased Linus Sully and his son Gilbert Laville. Laville sustained multiple injuries of the head and other parts of the body they were taken to the Marigot Hospital where the body of Linus Sully was pronounced dead by the doctor. Meanwhile Laville was referred to the Princess Margaret Hospital for further medical attention. A Coroner’s Inquest will be convened soon to be followed by a Post Mortem.”Dominica Vibes News Tweet Sharing is caring! Share Share 18 Views no discussions Share